Search company, investor...

Founded Year



Series A | Alive

Total Raised


Last Raised

$11.5M | 3 mos ago

About Briya

Briya focuses on healthcare and life sciences, operating in the domain of data management and research. The company offers a platform that enables real-time retrieval and sharing of harmonized longitudinal data, simplifying data discovery and access. It primarily serves healthcare providers, life science companies, and research institutions. It was founded in 2020 and is based in New York, New York.

Headquarters Location

New York, New York,

United States



Briya's Product Videos

Briya's Products & Differentiators

    Briya platform

    A medical data retrieval platform: Briya is an end-to-end decentralized platform enabling real time retrieval of harmonized longitudinal data.


Expert Collections containing Briya

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Briya is included in 3 Expert Collections, including Blockchain.



6,949 items

Companies in this collection build, apply, and analyze blockchain and cryptocurrency technologies for business or consumer use cases. Categories include blockchain infrastructure and development, crypto & DeFi, Web3, NFTs, gaming, supply chain, enterprise blockchain, and more.



7,289 items

These companies protect organizations from digital threats.


Digital Health

10,585 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Latest Briya News

Briya: Healthcare Data Exchange Platform Raises $11.5 Million In Funding

Sep 28, 2023

Briya – an end-to-end healthcare data exchange platform – recently announced the completion of an $11.5 million Series A round of financing, bringing the company’s total funding to $17 million. Team8 led this funding round, including existing investors Insight Partners and Amiti Ventures, and is joined by the George Kaiser Family Foundation. The funding round will support Briya’s mission to transform how data is exchanged between healthcare and life sciences organizations, emphasizing supporting the United States health ecosystem. And the company’s scalable data exchange platform enables hospitals to capitalize on their patient data. It has been implemented in healthcare systems and academic institutions, primarily in Europe and Israel. The Briya platform connects clinics and hospitals with academic and pharmaceutical research teams, addressing organizations’ challenges in collecting and exchanging healthcare data. And the highly secured data exchange empowers hospitals to effectively utilize their health data and safely share it, in compliance with all regulatory guidelines. And at the same time, it provides life sciences organizations seamless access to high-quality, de-identified real-world data to expedite development and time-to-market for new therapies. Briya’s blockchain-powered system standardizes all electronic health records, enabling better access to and exchange of live anonymized healthcare data for life sciences organizations. And this technology facilitates optimal use of a range of AI and machine learning tools, real-world data, and health economics studies to optimize clinical trials, ensure regulatory compliance, and accelerate drug discovery. The timing of this funding round highlights stakeholders’ confidence in the value Briya brings to the market by enabling healthcare organizations, researchers, and pharmaceutical organizations to exchange real-world healthcare data efficiently. KEY QUOTES: “By implementing Briya’s data platform, we can now quickly access relevant clinical and radiological data from various sources in mere seconds. This has not only increased our efficiency in clinical research but also improved our collaboration within our international research network, thanks to a decentralized approach, enhanced data security, and increased transparency in data processing. It ultimately enhances interoperability and data quality.” — Dr. Jawed Nawabi, a radiology specialist at the Institute of Neuroradiology at Charité – Universitätsmedizin Berlin, a Newsweek Top 10 global hospital, and Digital Clinician Scientist Fellow at the Berlin Institute of Health at Charité (BIH) “Briya has developed the only end-to-end solution currently on the market that streamlines the entire process of data sharing between healthcare organizations and life sciences organizations. It not only handles discovery, formatting, de-identification, and securing transfer of data, but also solves operational hurdles such as contracting, payments and approvals. This unique end-to-end vision, coupled with its cutting-edge technology, makes us confident that Briya will significantly improve the healthcare industry’s ability to make positive use of clinical data.” — Sarit Firon, Managing Partner of Team8, leading the group’s investment arm “Despite the abundance of available healthcare data, the fragmented nature of the current system, combined with complex compliance issues and a lack of standardization, means healthcare organizations face significant challenges in sharing their data with pharmaceutical and research partners, impeding medical research and care. Briya’s data exchange platform provides a scalable and secure model that allows hospitals to take full advantage of all that patient data has to offer, with minimal additional effort, to promote greater collaboration while generating lucrative revenue streams.” — David Lazerson, CEO and Co-founder of Briya “Privacy and speed are top priorities when it comes to digital health and Briya provides both the confidentiality and fast queries simultaneously. It is the most comprehensive decentralized data platform we have seen in recent years, helping us establish smart contracts to share data and reduce data storage costs. We expect to see Briya adopted as a scalable data exchange solution in institutes, hospitals, and organizations across the U.S. in the near future.” — Janet Meiling Wang-Roveda, professor of Electrical and Computer Engineering at the University of Arizona “Briya has enabled us to concentrate on pioneering research and innovation while fostering strategic partnerships with academia and the industry – all vital elements for our continued relevance in the age of AI. It has become an integral part of the hospital’s legacy of excellence, as well as the broader Israeli innovation ecosystem.” — Prof. Ronni Gamzu, CEO of the Tel Aviv Sourasky Medical Center Trending on Pulse 2.0

Briya Frequently Asked Questions (FAQ)

  • When was Briya founded?

    Briya was founded in 2020.

  • Where is Briya's headquarters?

    Briya's headquarters is located at New York.

  • What is Briya's latest funding round?

    Briya's latest funding round is Series A.

  • How much did Briya raise?

    Briya raised a total of $17M.

  • Who are the investors of Briya?

    Investors of Briya include Insight Partners, Amiti Ventures, George Kaiser Family Foundation, Team8 Capital, Intel Ignite and 3 more.

  • Who are Briya's competitors?

    Competitors of Briya include Owkin and 4 more.

  • What products does Briya offer?

    Briya's products include Briya platform.


Compare Briya to Competitors

Rhino Health Logo
Rhino Health

Rhino Health operates a healthcare data platform. It provides access to patient data required to develop and commercialize artificial intelligence (AI) models that deliver results across patient populations and allows healthcare artificial intelligence developers and medical researchers to access datasets. The company was founded in 2020 and is based in Boston, Massachusetts.

Aicura Medical Logo
Aicura Medical

Aicura Medical is a data and AI company operating in the healthcare and life sciences sector. The company offers a platform that streamlines data discovery, aggregation, and curation, and automates data and image analysis to accelerate clinical research. Aicura Medical primarily serves biotech firms, healthcare providers, medtech companies, clinical researchers, and Contract Research Organizations. It was founded in 2017 and is based in Berlin, Germany.

Decode Health Logo
Decode Health

Decode Health is a precision medicine analytics company that fuels collaboration within pharmaceutical, diagnostic, and technology companies. The company leverages its platform and expertise in genomics, clinical data, social determinants of health, and other healthcare data sources, to bring actionable insights into focus quickly. It creates data assets, products, and services that improve patient outcomes and reduce costs. Projects include genomic data creation, biomarker discovery, RNA diagnostics, and broader population health analytics. Decode Health was founded in 2019 and is headquartered in Nashville, Tennessee.


Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers.


SymetryML is a machine learning software company to create clinical and real-world evidence federations. The company offers machine learning, data science, analytics tool, and intelligence solutions. It was founded in 2020 and is based in Morristown, New Jersey.

Bio-AI Health

Bio-AI Health is a company focused on advancing precision medicine through the use of artificial intelligence in the healthcare sector. The company's main services include the development of patient profiling using AI, integrating biopharma clinical trial patient data and real-world evidence data to build predictive biomarker tests, and the use of their platform to determine which pathological and molecular factors play a role in patient response to therapy and drug resistance. Bio-AI Health primarily sells to the biopharma industry. It was founded in 2020 and is based in Goffstown, New Hampshire.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.